MedTrace Logo

Extracorporeal Shockwave Myocardial Revascularization in Refractory Angina

NCT03516643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2018-05-04

No results posted yet for this study

Summary

This is a prospective cohort study to examine the efficacy of ESMR application in patients with refractory angina despite optimal medical therapy, not suitable for further PCI or CABG. Characteristics such as angina class scores (CCS class score), nitroglycerin consumption and hospitalization were compared at baseline and 1, 6 and 12 months after ESMR therapy. The effect on cardiac perfusion was assessed at 6 months.

Conditions

  • Angina Refractory
  • Angina Pectoris

Interventions

OTHER

Extracorporeal Shockwave Myocardial Revascularization

extracorporeal shockwave in ischemic area evaluated by SPECT

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Gianluca Alunni · Città della Salute e della Scienza of Torino

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2018-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516643 on ClinicalTrials.gov